Takeda's dengue vaccine recommended by world health organization advisory group for introduction in high dengue burden and transmission areas in children ages six to 16 years

Osaka, japan & cambridge, mass.--(business wire)--takeda (tse:4502/nyse:tak) today announced that the world health organization's (who) strategic advisory group of experts (sage) on immunization shared recommendations for use of qdenga®▼ (dengue tetravalent vaccine [live, attenuated]) (tak-003). in the coming months, the who will consider the sage recommendation and update its position paper on dengue vaccines to include final guidance on the use of qdenga in public vaccination programs. sage m.
TAK Ratings Summary
TAK Quant Ranking